Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: D5 1/2NS
Total 0 results
Nothing found
Sponsors and Collaborators
Kettering Foundation
Prader-Willi Syndrome Association of Australia
NATURAmedicatrix Sàrl
Laboratoires Iprad-Vegebom
Sonogenix
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Resurge Therapeutics Inc.
Australian Childhood Foundation
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Zhijun Sun
Carlos III Health Institute
Sociedad Española de Arteriosclerosis
Remedy Institute
wenbinlu
Health Holding Company, Hail Health Cluster, Saudi Arabia
Epicentre, Paris, France.
Brigham and Womens' Hospital, Center for Surgery and Public Health
Paul W. Read, MD
View Full List
Medical Conditions
Stage IIIB Esophageal Adenocarcinoma
Adherence to In-Office Glaucoma Evaluation Appointment
Marginal Zone B-cell Lymphoma
Refractory B-Lineage Lymphoma
Lymphoblastic Lymphoma
Escape Room Games and Role Playing Gamification
Hernia,Ventral
Mycobacterium Avium Complex Infections
Stage III Childhood Anaplastic Large Cell Lymphoma
Neurobehavioral Manifestation
Pregnancy; Accident
Ankle Trauma
Cell Senescence
Intervention Studies
Stroke Recrudescence
Psychoactive Substance Use
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Apneic; Oxygenation
Malignant Tumor of Extrahepatic Bile Duct
Spinocerebellar Ataxia Genotype Type 3
View Full List
Drug Interventions
Optiva artificial tear by Allergan
Colecalciferol D3 (Vigantol Oil)
Epalrestat
Gadoteridol (ProHance)
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
LINjeta U-100 Insulin
SBI-087
300 mg of caffeine citrate infusion
Low molecular weight Heparin as standard of care treatment
Fostamatinib
Everolimus
Lansoprazole 15mg QD
Fenofibric acid 135mg
Irinotecan
Oral Aztreonam
Triple therapy
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
ART-123
Omeprazole 40 mg
FRSW107
View Full List
CROs by country
Contract Research Organizations in Cambodia
Contract Research Organizations in Dominican Republic
Contract Research Organizations in France
Contract Research Organizations in India
Contract Research Organizations in Italy
Contract Research Organizations in Nigeria
Contract Research Organizations in Panama
Contract Research Organizations in Senegal
Contract Research Organizations in Spain
Contract Research Organizations in Tanzania
Contract Research Organizations in Thailand
Contract Research Organizations in Ukraine
Contract Research Organizations in United States
CRO list by country
CROs in Brazil
ICON
ODC
Charles River Laboratories
Dokumeds
Raras CRO
Rede Optimus Hopitalar AG
AZD Brasil
Gon1 biotecnologia e pesquisa
Synova Health
Centro Paulista de Investigação Clinica (CEPIC)
All CROs in Brazil
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe